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Abstract 
An automated attenuation correction and normalisation algorithm was developed to improve 
the quantification of contrast enhancement in ultrasound images of carotid arteries. The 
algorithm first corrects attenuation artefact and normalises intensity within the contrast agent-
filled lumen and then extends the correction and normalisation to regions beyond the lumen. 
The algorithm was first validated on phantoms consisting of contrast agent-filled vessels 
embedded in tissue-mimicking materials of known attenuation. It was subsequently applied to 
in vivo contrast-enhanced ultrasound (CEUS) images of human carotid arteries. Both in vitro 
and in vivo results indicated significant reduction in the shadowing artefact and improved 
homogeneity within the carotid lumens after the correction. The error in quantification of 
microbubble contrast enhancement caused by attenuation on phantoms was reduced from 
55% to 5% on average. In conclusion, the proposed method exhibited great potential in 
reducing attenuation artefact and improving quantification in contrast-enhanced ultrasound of 
carotid arteries. 
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Introduction 
 
Stroke is a major cause of mortality, morbidity and long-term disability, resulting in a 
substantial economic burden on health and social services (Murray and Lopez 1997). Carotid 
atherosclerotic plaque is one of the major preventable causes of stroke (U-King-Im et al. 
2009). Plaques at risk of rupture (vulnerable plaques) are not necessarily those that impinge 
most substantially upon the lumen (Topol and Nissen 1995). Nevertheless, current clinical 
imaging investigations still focus on quantifying the degree of luminal stenosis and, hence, 
are relatively poor at predicting which patients will suffer a stroke. Recent studies have 
identified plaque neovascularisation as being a key feature of vulnerable plaques (Hellings et 
al. 2010; Virmani et al. 2006). Furthermore, abnormal proliferation of adventitial vasa 
vasorum (VV) occurs early at sites of atherosclerosis and is thought to be a precursor to 
atherosclerosis and an early biomarker of vascular damage (Feinstein 2006; Macioch et al. 
2004). An imaging tool capable of detecting and quantifying such vascular features would 
offer valuable information for the diagnosis and management of this important disease. 
 
Ultrasonography (US) is regarded as one of the most promising tools in assisting diagnosis 
and management of carotid artery disease because of its non-ionizing nature and real-time 
imaging in good spatial resolution, with relatively low cost and high accessibility. Recently, 
contrast-enhanced ultrasound (CEUS) has made it possible to image and quantify 
neovascularisation in plaques as well as adventitial VV (Feinstein 2006). However, current 
quantification of contrast enhancement is significantly limited by spatially heterogeneous and 
patient-specific attenuation (Tang et al. 2008, 2011). During a US scan, ultrasound echo from 
a target is affected by attenuation between the US transducer and the target. Time gain 
compensation (TGC) is commonly used for correcting attenuation where echo signals are 
amplified as a function of time, so the further the echoes come from, the higher the signal 
gain is. However, such TGC cannot account for spatially heterogeneous attenuation caused 
by either heterogeneous tissue distribution or non-uniform contact between the probe and 
skin. It is also difficult for TGC to account for variations in tissue attenuating properties 
across patient populations. Consequently, it is common to see (i) shadowing in vascular 
ultrasound images (e.g., see Fig. 1), a manifestation of spatially heterogeneous attenuation; 
and (ii) variations in image intensity between patients, a manifestation of population variation. 
It should be noted that attenuation may not be visually identifiable because of image 
compression at display, but can still cause significant errors in quantification based on image 
intensity, which limits the usefulness of quantification of CEUS in clinical applications. 
Although there have been studies on correction of attenuation in CEUS images in general 
(Mari et al.  2010; Mule et al. 2008; Tang et al. 2008), we are not aware of any study on 
CEUS images of carotid arteries where accurate quantification of plaque neovascularisation 
and abnormal proliferation of VV is valuable. 
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Fig. 1. Regions of interest (ROI) in the lumen (solid line) and vessel wall (dashed line). 
 
The objective of this study was to develop an attenuation correction and normalisation 
technique for CEUS carotid artery imaging, to correct for spatially heterogeneous and 
patient-specific attenuation and thus improve the quantification of contrast enhancement in 
plaques and VV. This technique was initially validated on a carotid artery-mimicking 
phantom and then, as an initial clinical demonstration, applied to ultrasound contrast 
enhancement in carotid artery vessel wall in a cohort of patients. 
 
Methods 
Attenuation correction and image normalisation algorithms 
An attenuation correction algorithm for CEUS carotid artery images was developed based on 
the assumption that microbubble contrast agents are well mixed in the lumen, and hence, the 
image intensity across the vessel lumen should be homogeneous (except for intensity 
variations caused by speckle) if attenuation is properly corrected for. Microbubbles, when 
injected intravenously, are expected to have been well mixed in the flow when they arrive at 
the carotid artery. On the basis of this assumption, the algorithm initially estimates and 
corrects for the attenuation within the carotid lumen and then extends the correction at the 
lumen boundary to the vessel wall next to the lumen. Furthermore, the images are normalised 
so that quantification of contrast enhancement is less affected by variations in patient dose of 
contrast agents. 
 
Analysis of CEUS video sequences was performed off-line using software developed in-
house using MATLAB (The MathWorks, Natick, MA, USA). Regions of interest (ROIs) 
were selected manually, one to segment the lumen and the others to include regions in 
adventitia where quantification is required (Fig. 1). The motion of the lumen and adventitia 
ROIs in the video sequence was tracked and corrected by employing a piecewise block 
matching algorithm (Briechle and Hanebeck 2001; Golemati et al. 2003). As a result of 
motion correction, all images in the sequence were aligned to the first image. 
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The attenuation correction algorithm consists of the following specific steps. All 
computations were performed on linearised video data. The video data are log compressed; 
linearised video data refer to the anti-log decompressed video data. 
1. Based on the segmented lumen, the relative smoothed intensity profile A, which is a 
function of accumulated attenuation within the lumen, was estimated by adopting a 
low-pass Gaussian filter (Tang et al. 2008) as indicated in the equation 
Alumen(x,y) = Ilumen(x,y)  G(x,y) (1) 
where G(x,y) = 
1
2𝜋𝜎2
∙ 𝑒
− 
𝑥2+𝑦2
2𝜎2 , x and y are spatial coordinates,  denotes convolution  
The choice of σ, the standard deviation of the Gaussian kernel, depends on the imaging 
settings. Here the standard deviation is set to be at least twice the speckle size measured on 
the image for both phantom and in vivo studies. Such a filter diminishes the speckle and 
leaves the spatially smoothed intensity profile. One issue with the filtering is that at the 
boundary of the lumen, the filter covers pixels outside the lumen. To resolve this issue, a 
mirror image approach was adopted; that is, the pixels outside the bounds of the lumen were 
computed by mirror reflecting the lumen across the lumen border.  
2. The attenuation correction was performed within the segmented lumen as described in 
the equation 
CIlumen(x,y) = Ilumen(x,y) / ( Alumen(x,y) + regulariser ) (2) 
where CIlumen(x,y) denotes corrected image within the lumen. 
The regulariser is a constant that avoids the over-amplification of noise when Alumen in the 
denominator in eqn (2) becomes close to zero. It plays a crucial role in this correction process, 
as too large a regulariser would leave the image uncorrected, and too small a regulariser 
would cause overcompensation because of noise. In this study, the value of the regulariser is 
set at 0.08 for the phantom study and 0.1 for the in vivo study. These values are obtained by 
minimising the normalised intensity fluctuation (NIF) within the corrected lumen defined as 
𝑁𝐼𝐹 =
√∑(𝐶𝐼(𝑥, 𝑦) − 〈𝐶𝐼(𝑥, 𝑦)〉)
2
〈𝐶𝐼(𝑥, 𝑦)〉
 
(3) 
where CI is the intensity of pixel at position (x,y), and <CI(x,y)> is the spatial average 
intensity within corrected lumen. The variation of this index as a function of the regulariser 
for the phantom study is illustrated in Figure 2. 
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Fig. 2. Normalised intensity fluctuation (NIF) within a corrected lumen. 
 
3. Based on the estimated CIlumen(x,y), which covers the whole lumen, the correction 
factors at the lower (Alb) and upper (Aub) boundaries of the lumen were extended to 
regions below (Ilr) and above the lumen (Iur), including the adventitia, using 
CIur (x,y) = Iur (x,y) / ( 𝐴𝑢𝑏 (𝑥, 𝑦) + regulariser )   
(4) 
 
CIlr (x,y) = Ilr (x,y) / (𝐴𝑙𝑏 (𝑥, 𝑦) + regulariser ) 
Image normalisation 
The image is then normalised by the mode intensity within the lumen. After normalisation, 
the peak in the lumen intensity histogram is located at intensity equal to one. This is to reduce 
the variations in CEUS quantification caused by variations in both tissue attenuation 
properties and contrast concentration in different patients. 
 
Evaluation of lumen intensity homogeneity 
 
As a first step in evaluation of the attenuation correction algorithm, image intensity 
histograms were generated to characterise the change in intensity homogeneity within the 
lumen before and after the correction. The full width at half-maximum (FWHM) of the peak 
in the lumen intensity histogram is calculated as a measure of lumen intensity homogeneity.  
 
Phantom setup and validation 
The attenuation correction algorithm was first validated on a carotid artery-mimicking 
phantom constructed in-house and illustrated in Figure 3. It consisted of two contrast agent-
filled vessels embedded in a tissue-mimicking phantom (TMM2) (Madsen et al. 1998). The 
first vessel simulates the carotid artery, and the second is 1 cm below the first, representing 
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target regions containing microbubble contrast agents whose concentration needs to be 
quantified. An additional attenuating material (TMM1) was placed under the probe and 
covering half of the TMM2, causing additional attenuation to only half of the phantom. 
Although the function of the upper vessel was to mimic the carotid artery, the function of the 
lower vessel was to create a region with controlled bubble concentration. Given that the 
microbubbles were well mixed and the TMMs under the tube are homogeneous, such a setup 
offers both measurements with attenuation (left-hand side [LHS]) and control measurements 
(right-hand side [RHS]) within the same image acquisition, and any extra signal loss on the 
LHS of the phantom compared with the RHS is due to the attenuation caused by the 
additional attenuation material. 
 
Fig. 3. Carotid artery-mimicking setup with additional attenuation material (TMM1) on the    
left-hand side of the phantom. TMM = tissue-mimicking material. 
 
TMM1 and TMM2 were constructed according to the protocol of Madsen et al. (1998). The 
estimated attenuation of TMM1 or TMM2 was 0.5 dB cm21 MHz–1. Homemade lipid shell 
microbubbles were used at two concentrations: 7.50  106/mL and 3.75  106/mL. An 
AplioXG scanner (PLT-704 SBT, 4- to 11-MHz linear probe, Toshiba, Tokyo, Japan) was 
used to scan the phantom with the following settings: mechanical index = 0.1, gain = 70, 
dynamic range = 80, TGC = manually adjusted, frequency = 4/8 MHz. Two groups of ROIs 
(bubble regions within the lower vessel and tissue regions below that vessel) were selected on 
both the attenuated and control sides of the phantom (Fig. 4), and the average intensities 
before and after attenuation correction were compared. The locations of ROIs are indicated in 
Figure 4, including regions for attenuated bubble signals, unattenuated bubble signals, 
attenuated tissue signals and unattenuated tissue signals. 
 
Clinical application (vessel wall) 
Forty-eight patients previously treated for head and neck cancer (HNC) with at least one risk 
factor for atherosclerosis were recruited from a cancer centre. The study was approved by the 
institutional research and ethics committee, and each patient provided informed consent. 
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CEUS image sequences were acquired on both sides of the neck with a clinical scanner (GE 
Vivid 7 with a 9-MHz broadband linear array transducer). A GE scanner (Vivid 7, linear 
array 9L transducer, GE Healthcare) was used to scan the phantom with the following 
settings: mechanical index = 0.21, gain = 0, dynamic range = 54, TGC = manually adjusted, 
frequency = 3.2/6.4 MHz. Contrast-enhanced ultrasound video loops were taken using a 
commercially available ultrasound contrast agent, SonoVue (Bracco, Milan, Italy), given as 
an intravenous infusion via a peripheral vein at the rate of 1.2 mL/min. The infusion was 
delivered over a total of 5–7 min. Imaging was performed in real time before arrival of and 
after saturation of the carotid artery with SonoVue. 
 
The FWHM of lumen intensity histogram for both uncorrected and corrected images was 
calculated. 
 
Statistical analysis 
The FWHM of lumen intensity histograms across the patient population are presented as 
means and standard deviations (SD). The FWHM of lumen intensity histograms of 
uncorrected and corrected images were compared using paired-sample t-tests. A two-tailed 
test was used, with  set at 0.05. Statistical analyses were performed using on-line Prism 6 
software (GraphPad, La Jolla, CA, USA). 
 
Results 
Phantom validation 
Images of the phantom before and after correction are provided in Figure 4. The image 
intensity in the lumen on the LHS is significantly attenuated before correction and is restored 
to a level similar to that on the RHS after correction. The attenuated tissue region under the 
vessel on the LHS has also been compensated. Note that the difference in speed of sound 
between the additional attenuation material and water caused some slight image distortion for 
the phantom. 
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Fig. 4. Contrast-enhanced ultrasound images of a carotid artery-mimicking phantom before 
and after attenuation correction with B-mode images as reference. Regions of interest (ROIs) 
with solid outlines represent regions of attenuated bubble signals (bubble attenuated), ROIs 
with dashed outlines represent regions of unattenuated bubble signals (bubble control), ROIs 
with long-dashed lines represent regions of attenuated tissue signals (tissue attenuated) and 
ROIs with round dotted lines represent regions of unattenuated tissue signals (tissue control). 
TMM = tissue-mimicking material. 
 
Table 1 (A, B) summarizes the ROI measurements of the phantom with high bubble 
concentration before and after attenuation correction. It can be seen that the intensity error for 
quantification of microbubble signals was reduced from 61% to 7% after correction. 
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Table 1A Bubble ROIs measurement of phantom before and after attenuation correction 
(high concentration) 
 
ROI (bubble — 
control)   
ROI (bubble — 
attenuated) uncorrected 
ROI (bubble — 
attenuated)  corrected 
Intensity 
(mean±SD) 
1.11±0.053 0.439±0.058 1.03±0.029 
 Difference 
to control 
  61%±9% 7%±9% 
 
Table 1B Tissue ROIs measurement of phantom before and after attenuation correction 
(high concentration) 
 
ROI (tissue — 
control)   
ROI (tissue — attenuated)  
uncorrected 
ROI (tissue — 
attenuated)  corrected 
Intensity 
(mean±SD) 
0.670±0.018 0.283±0.017 0.600±0.033 
 Difference 
to control 
 58%±2% 10%±4% 
 
 
 
Table 2 (A, B) summarizes the ROI measurements of the phantom with low bubble 
concentration before and after attenuation correction. It can be seen that the intensity error for 
quantification of microbubble signals was reduced from 48% to 2% after correction. 
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Table 2A Bubble ROIs measurement of phantom before and after attenuation correction 
(low concentration) 
 
ROI (bubble — 
control)  
ROI (bubble — 
attenuated)  uncorrected 
ROI (bubble — 
attenuated)  corrected 
Intensity 
(mean±SD) 
0.819±0.103 0.429±0.026 0.838±0.047 
 Difference 
to control 
 48%±6% 2%±9% 
 
Table 2B Tissue ROIs measurement of phantom before and after attenuation correction (low 
concentration) 
 
ROI (tissue — 
control)   
ROI (tissue — attenuated)  
uncorrected 
ROI (tissue — attenuated)  
corrected 
Intensity 
(mean±SD) 
0.683±0.008 0.275±0.012 0.538±0.044 
 Difference 
to control 
 60%±6% 21%±9% 
 
In vivo results 
Contrast-enhanced ultrasound images of carotid arteries before and after attenuation 
correction are provided in Figure 5. It can be seen that in both cases, part of the lumen is 
darker than the rest before the correction, and such attenuation artefacts are corrected for after 
applying the developed algorithms. Visually, the shadowing in the image was removed. In 
addition, the visualization of contrast enhancement in the vessel wall was improved. 
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Fig. 5. Examples of contrast-enhanced ultrasound images of carotid arteries before and after 
attenuation correction. Top row: Patient A before (a) and after (b) attenuation correction. 
Bottom row: Patient B before (c) and after (d) attenuation correction. 
 
Histogram of lumen intensity and FWHM evaluation 
 
Lumen intensity histograms for the two patients are illustrated in Figure 6. The FWHM of the 
intensity histogram within the lumen was reduced from 0.350 (Fig. 6a) to 0.195 (Fig. 6b) 
after attenuation correction for patient A and from 0.500 (Fig. 6c) to 0.150 (Fig. 6d) for 
patient B. 
 
Fig. 6. Image intensity within lumen before and after attenuation correction. Top row: Patient 
A before (a) and after (b) attenuation correction. Bottom row: Patient B before (c) and after 
(d) attenuation correction. 
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The FWHMs of lumen intensity histogram for all 48 patients were compared before and after 
attenuation correction. The mean ± SD of the FWHM was 0.346 ± 0.138 before and 0.135 ± 
0.038 after the correction, representing a 61.0% decrease in FWHM with the corrected image 
compared with the uncorrected one. This decrease in FWHM is statistically significant 
(paired t-test, p  0.0001). 
 
Discussion 
An attenuation correction and image normalisation method for CEUS carotid artery images 
has been developed for more reliable quantification of contrast enhancement. The method 
uses the lumen as a reference, where the image brightness is assumed to be homogeneous if 
attenuation is properly corrected. Our initial results on phantoms and in vivo carotid arteries 
indicate that the correction method significantly reduces attenuation artefact. On phantom 
evaluation, the error in quantifying microbubble contrast enhancement caused by attenuation 
is reduced from 48%–61% to 2%–7%. For in vivo data, the correction improved the lumen 
homogeneity, measured as FWHM of the lumen intensity histogram, by 61% on average. 
 
The method assumes that microbubbles are well mixed across the lumen and, therefore, that 
image bright-ness should be homogeneous if attenuation is properly corrected. This is a 
reasonable assumption, as the micro-bubbles are injected as an intravenous infusion, and by 
the time they get to the carotid artery they would have been well mixed in blood. 
 
The correction algorithm includes two parameters: the Gaussian spatial low-pass filter size 
and the regulariser. These are independent of each other. The filter size (sigma) is determined 
by the size of the speckle (it needs to be large enough to remove the speckle), whereas the 
regulariser is determined by the system noise level. 
 
There are a range of imaging variables including ultrasound scanner settings such as 
frequency, mechanical index, various gain settings and dynamic range and the type of scan 
format (linear or sector). The proposed algorithms are not expected to be significantly 
affected by the variations in most of these factors in general, as they do not violate the model 
assumption: microbubbles within vessel lumen are well mixed and hence vessel lumen 
signals should be homogeneous. However, some factors, such as dynamic range, if set too 
low, could cause image saturation and hence affect the results. 
 
To illustrate the effect of attenuation in both the axial and lateral directions, we have 
performed correction in the x-direction alone by averaging the estimated attenuation 
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vertically and compared with the correction in both directions. From Figure 7d, it can be seen 
that the attenuation in both directions is significant and should be corrected. 
 
Fig. 7. Top row: Attenuation correction in both x- and y-directions—(a) contrast-enhanced 
ultrasound image and (b) image intensity histogram within lumen after attenuation correction. 
Bottom row: Attenuation correction in x-direction only—(c) contrast-enhanced ultrasound 
image and (d) image intensity histogram within lumen after attenuation correction. 
 
Besides attenuation, non-linear imaging artefacts (Tang and Eckersley 2006; Tang et al. 2010) 
also commonly exist in CEUS images. Such artefacts originate from the assumption of totally 
linear ultrasound transmission and propagation, on one hand, and the non-linear propagation 
of the transmitted ultrasound pulse through tissue and/or microbubble clouds in reality, on the 
other hand (Tang and Eckersley 2006;  Tang et al. 2010). These artefacts vary with both 
ultrasound amplitude and frequency. Clinical examples of such artefacts have recently been 
reported (Ten Kate et al. 2012; Van den Oord et al. 2013). In the present study, the 
quantification results are likely to contain, besides desirable neovascularisation and VV 
signals, significant undesirable non-linear artefacts. It is important to address both attenuation 
and the non-linear artefacts to achieve reliable quantification in CEUS images. We are 
currently working on correction of non-linear artefacts, and initial results have already been 
reported (Yildiz et al. 2015) with the aim of incorporating this into our software. Currently, 
further use of our software in a clinical setting would be suitable for quantifying differences 
in contrast intensity between patients and controls, where there is a reasonable expectation 
that non-linear imaging artefacts would be similar for both groups. 
 
Attenuation artefacts in CEUS images, together with other factors, have made reliable 
quantification difficult and have led to diagnostic uncertainty. This is the first study, as far as 
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we are aware, to develop attenuation and normalisation techniques for CEUS carotid images. 
It does not require modification to any imaging system hardware and can be packaged as a 
software module and integrated into existing commercial ultrasound scanners. Although in 
this work the correction of attenuation and normalisation were conducted offline, real-time 
processing is feasible, as the algorithm involves only simple filtering and division. Currently 
the more time-consuming part is the manual lumen segmentation and motion tracking, but 
given that the algorithm does not depend on accurate lumen segmentation and tracking, it is 
feasible for these to be done in real time. This technique has potential to be extended to other 
views of carotid arteries, and this requires further studies. In addition, quantification of 
neovascularisation may be tested in a clinical setting as a possible early surrogate biomarker 
of atherosclerosis against validated surrogates of stroke risk such as intima–media thickness 
to determine if there is any clinical correlation. The use of controls would be valuable in 
determining changes related specifically to signal intensity caused by neovascularisation, 
both in the adventitia and in plaques. 
 
Conclusions 
Our attenuation correction and normalisation method resulted in a significant reduction of 
attenuation artefacts both on a carotid artery-mimicking phantom and in vivo. This represents 
a step toward reliable quantification of contrast enhancement in CEUS carotid images. 
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